Status:
COMPLETED
Finding New Targets by Proteomic Approaches (InnovRT1)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut Curie
Sainte Anne hospital
Conditions:
ATRT
Eligibility:
All Genders
Up to 17 years
Brief Summary
The investigators aim to explore the inter tumor heterogeneity by a proteomic approach of a wide series of rhabdoid tumors, from both intra and extra cranial origins.
Detailed Description
Context: Rhaboid tumors (RT) are aggressive cancers of young infants, exposed to the toxicity of heavy treatments often ineffective, which justifies the need to identify new treatment strategies. Thes...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Aged 0-17 years old
- Rhabdoid tumor, treated in oncology departments in Ile de France
- frozen samples collected in usual care
- parents' agreement for samples collection in usual care
- Exclusion Criteria
- Unconfirmed diagnosis of Rhabdoid tumor with molecular analyses Samples
- paraffin embedded tissues
Exclusion
Key Trial Info
Start Date :
August 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 17 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04868799
Start Date
August 12 2022
End Date
February 17 2023
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de neurochirurgie - Hôpital Necker Enfants malades
Paris, France, 75015